<?xml version="1.0" encoding="UTF-8"?>
<p>The suppressive activity on respiratory oxidative burst by harpagide 5-O-Î²-D-glucopyranoside is further corroborated by its ability to suppress T-cell proliferation (
 <xref ref-type="fig" rid="F0004">Figure 4B</xref>). Proliferation of T-cell has been implicated in the activation of CRS, and studies have suggested that targeting T-cell proliferation may suppress the severe progression of COVID-19 (Zhou et al., 
 <xref rid="CIT0078" ref-type="bibr">2020</xref>).
</p>
